Profile data is unavailable for this security.
About the company
AVE Science & Technology Co Ltd is a China-based company principally engaged in the research and development, production, sales and service of medical clinical laboratory analysis instruments and supporting in vitro diagnostic reagents and medical consumables. The Company’s main products include urine formed component analyzer, urine dry chemistry analyzer, urine full item automatic analyzer, automatic stool analyzer, automatic body fluid analyzer, reproductive tract secretion analyzer, and special supporting in vitro diagnostic reagents and medical consumables and other products. The Company's products are mainly used in inspection departments of various medical and health institutions. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)197.06m
- Net income in CNY18.21m
- Incorporated2000
- Employees545.00
- LocationAVE Science & Technology Co LtdAVE Medical Technology Park, No. 26Fuling Road, Xueshi Neighborhood, YueluCHANGSHA 410208ChinaCHN
- Phone+86 73 189715453
- Fax+86 73 188907046
- Websitehttp://www.c-ave.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AVE Science & Technology Co Ltd | 197.06m | 18.21m | 1.10bn | 545.00 | 54.43 | 2.01 | -- | 5.03 | 0.2679 | 0.2679 | 2.90 | 7.24 | 0.3621 | 2.07 | 24.54 | 361,569.20 | 3.35 | -- | 3.67 | -- | 53.89 | -- | 9.24 | -- | 5.27 | -- | 0.00 | -- | -6.60 | -- | -42.53 | -- | -- | -- |
| Hangzhou Tianmushan Phrmtcl ntrprs C Ltd | 116.72m | -64.77m | 1.13bn | 371.00 | -- | -- | -- | 9.18 | -0.5319 | -0.5319 | 0.9585 | -0.3456 | 0.3386 | 1.82 | 3.31 | 314,613.60 | -19.22 | -5.06 | -109.02 | -13.66 | 22.69 | 36.32 | -56.77 | -10.03 | 0.4755 | -7.43 | 1.25 | -- | -25.95 | -9.19 | -126.70 | -- | -43.72 | -- |
| Shanghai Rendu Biotechnology Co Ltd | 180.85m | -8.77m | 1.20bn | 528.00 | -- | 1.17 | -- | 6.16 | -0.2192 | -0.2192 | 4.52 | 23.78 | 0.1695 | 1.82 | 1.99 | 342,521.40 | -0.8215 | -- | -0.8869 | -- | 70.19 | -- | -4.85 | -- | 13.78 | -- | 0.008 | -- | 3.95 | -- | -63.89 | -- | -- | -- |
| Shanghai Rightongene Biotechnlgy Co Ltd | 350.71m | 22.68m | 1.41bn | 503.00 | 58.26 | 1.37 | -- | 3.77 | 0.4064 | 0.4064 | 6.33 | 17.30 | 0.3352 | 1.75 | 1.63 | 697,237.10 | 3.17 | -- | 3.41 | -- | 68.32 | -- | 9.47 | -- | 11.16 | -- | 0.0338 | -- | 45.83 | -- | -14.49 | -- | -- | -- |
| Shanghai Serum Bio-Technology Co Ltd | 190.92m | 52.16m | 1.54bn | 308.00 | 27.18 | 1.30 | -- | 7.43 | 0.482 | 0.482 | 1.76 | 10.08 | 0.1666 | 0.9371 | 5.88 | 619,870.90 | 4.55 | -- | 4.65 | -- | 76.65 | -- | 27.32 | -- | 45.16 | -- | 0.0122 | -- | -16.52 | -- | -16.14 | -- | -- | -- |
| Shaanxi Kanghui Pharmaceutical Co Ltd | 588.60m | -70.10m | 1.60bn | 828.00 | -- | 1.46 | -- | 2.44 | -0.7018 | -0.7018 | 5.89 | 9.84 | 0.289 | 2.23 | 3.02 | 710,868.00 | -4.51 | 1.41 | -6.35 | 1.71 | 30.41 | 45.74 | -15.60 | 4.48 | 0.8839 | -2.79 | 0.4034 | 32.34 | 11.01 | 6.01 | -272.84 | -- | 107.49 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2023 | 587.04k | 4.24% |
| Gfund Management Co., Ltd.as of 30 Jun 2023 | 47.94k | 0.35% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2023 | 29.35k | 0.21% |
| Lion Fund Management Co., Ltd.as of 30 Jun 2023 | 5.20k | 0.04% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 3.78k | 0.03% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 1.26k | 0.01% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 1.26k | 0.01% |
| Golden Eagle Asset Management Co., Ltd.as of 30 Jun 2023 | 1.26k | 0.01% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2023 | 1.26k | 0.01% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2023 | 1.26k | 0.01% |
